Andrew Fensome

3PUBLICATIONS
7CO-AUTHORS
Nanotoxicology, health and safetyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 01, 2026
The 5'-Isobutyryl Ester Prodrug of 4'-Thiouridine Inhibits SARS-CoV‑2 Replication in Culture and in a Syrian Hamster Infection Model.

|Aug 14, 2020
Discovery of Tyrosine Kinase 2 (TYK2) Inhibitor (PF-06826647) for the Treatment of Autoimmune Diseases.

Brian S Gerstenberger, Catherine Ambler, Eric P Arnold

|Aug 17, 2018
Dual Inhibition of TYK2 and JAK1 for the Treatment of Autoimmune Diseases: Discovery of (( S)-2,2-Difluorocyclopropyl)((1 R,5 S)-3-(2-((1-methyl-1 H-pyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone (PF-06700841).

Andrew Fensome, Catherine M Ambler, Eric Arnold

Pageof 1

Frequent Collaborators

1 joint publications

Brian S Gerstenberger

1 joint publications

Dafydd R Owen

1 joint publications

Stephen W Wright

1 joint publications

Franck Amblard